Coherus Oncology, Inc.

CHRS · Healthcare

$1.37

Markedsværdi: 211.67M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Coherus Oncology, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire31. aug. 2026, 13.30

Coherus to Participate in Upcoming Investor Conferences

GlobeNewswire17. aug. 2026, 21.33

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

Motley Fool13. aug. 2026, 00.31

Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript

GuruFocus.com6. aug. 2026, 05.03

Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: LOQTORZI Growth and Pipeline ...

Zacks5. aug. 2026, 22.10

Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates